Reviva Pharmaceuticals Holdings, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
Reviva Pharmaceuticals Holdings, Inc. (RVPH) reported Adjustments to Additional Paid in Capital, Warrant Issued of $5.15 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-08-12
- Reviva Pharmaceuticals Holdings, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2026-06-30 was $0.00.
- Reviva Pharmaceuticals Holdings, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2026-03-31 was $5.15M.
- Reviva Pharmaceuticals Holdings, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-09-30 was $4.70M.
- Reviva Pharmaceuticals Holdings, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-06-30 was $1.08M.
- Reviva Pharmaceuticals Holdings, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2024 was $165.95K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $5.15M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $5.15M 10-Q · filed 2026-05-13 | ||
| 2025-09-30 | $4.70M 10-Q · filed 2025-11-13 | ||
| 2024-12-31 | $165.95K 10-K · filed 2026-03-30 | ||
| 2024-06-30 | $1.08M 10-Q · filed 2024-08-14 | $1.08M 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |